Literature DB >> 20563739

Proteomics analysis of MPP+-induced apoptosis in SH-SY5Y cells.

Hongrong Xie1, Ming Chang, Xinyu Hu, Danping Wang, Mingxiu Tian, Guoyi Li, Huiyi Jiang, Ying Wang, Zhong Dong, Yuhua Zhang, Linsen Hu.   

Abstract

Accumulating evidence suggests that oxidative stress plays a pivotal role in dopaminergic neurodegeneration. However, the kinds of proteins involved in the response to oxidative stress remain unclear. In the present study, SH-SY5Y cells were treated with neurotoxin 1-methyl-4-phenyl-pyridinium ion (MPP+) to induce apoptotic neuronal injury. 2D-DIGE followed by MALDI-TOF-MS was used to determine the changing protein levels. Proteomics analysis revealed that 22 proteins were differentially altered in MPP(+)-treated SH-SY5Y cells, of which 7 were up-regulated proteins and 15 were down-regulated proteins, respectively. Three protein spots were unambiguously identified as sorcin, annexin V, and ribosomal protein P0. The three proteins showed a significant increase in level, suggesting a role in MPP(+)-induced apoptosis. The functional roles of these three proteins collectively indicate that multiple mechanisms are pertinent in the underlying pathogenesis of Parkinson's disease (PD), such as apoptosis, calcium homeostasis, and DNA insults.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20563739     DOI: 10.1007/s10072-010-0340-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  25 in total

1.  Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.

Authors:  E Diaz-Blanco; I Bruns; F Neumann; J C Fischer; T Graef; M Rosskopf; B Brors; S Pechtel; S Bork; A Koch; A Baer; U-P Rohr; G Kobbe; A von Haeseler; N Gattermann; R Haas; R Kronenwett
Journal:  Leukemia       Date:  2007-01-25       Impact factor: 11.528

2.  Knock-down of sorcin induces up-regulation of MDR1 in HeLa cells.

Authors:  Megumi Kawakami; Tsutomu Nakamura; Noboru Okamura; Chiho Komoto; Svetlana Markova; Hironao Kobayashi; Naofumi Hashimoto; Katsuhiko Okumura; Toshiyuki Sakaeda
Journal:  Biol Pharm Bull       Date:  2007-06       Impact factor: 2.233

3.  Proteomic changes of PC12 cells treated with proteasomal inhibitor PSI.

Authors:  Lei Zhang; Ming Chang; Hongjie Li; Shu Hou; Yu Zhang; Yihong Hu; Wei Han; Linsen Hu
Journal:  Brain Res       Date:  2007-03-30       Impact factor: 3.252

Review 4.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.

Authors:  Michael T Lin; M Flint Beal
Journal:  Nature       Date:  2006-10-19       Impact factor: 49.962

5.  Decreased concentration of annexin V in parkinsonian cerebrospinal fluid: speculation on the underlying cause.

Authors:  I Vermes; E N Steur; C Reutelingsperger; C Haanen
Journal:  Mov Disord       Date:  1999-11       Impact factor: 10.338

6.  Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

Authors:  J W Langston; P A Ballard
Journal:  N Engl J Med       Date:  1983-08-04       Impact factor: 91.245

Review 7.  Molecular pathogenesis of Parkinson's disease.

Authors:  Sonia Gandhi; Nicholas W Wood
Journal:  Hum Mol Genet       Date:  2005-08-26       Impact factor: 6.150

8.  Sorcin interacts with sarcoplasmic reticulum Ca(2+)-ATPase and modulates excitation-contraction coupling in the heart.

Authors:  Tomo Matsumoto; Yuji Hisamatsu; Tomoko Ohkusa; Noriko Inoue; Takashi Sato; Shinsuke Suzuki; Yasuhiro Ikeda; Masunori Matsuzaki
Journal:  Basic Res Cardiol       Date:  2005-03-09       Impact factor: 17.165

9.  TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+).

Authors:  Senthil Selvaraj; John A Watt; Brij B Singh
Journal:  Cell Calcium       Date:  2009-08-19       Impact factor: 6.817

10.  Complex modulation of L-type Ca(2+) current inactivation by sorcin in isolated rabbit cardiomyocytes.

Authors:  Mark R Fowler; Gianni Colotti; Emilia Chiancone; Yoshiharu Higuchi; Tim Seidler; Godfrey L Smith
Journal:  Pflugers Arch       Date:  2008-09-02       Impact factor: 3.657

View more
  7 in total

1.  Identification of chaperones in a MPP+-induced and ATRA/TPA-differentiated SH-SY5Y cell PD model.

Authors:  Hongrong Xie; Hui Hu; Ming Chang; Dongya Huang; Xiaobo Gu; Xinli Xiong; Ran Xiong; Linsen Hu; Gang Li
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

2.  Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.

Authors:  C J Yong-Kee; E Sidorova; A Hanif; G Perera; J E Nash
Journal:  Neurotox Res       Date:  2011-07-20       Impact factor: 3.911

3.  Specific changes of serum proteins in Parkinson's disease patients.

Authors:  Wenwen Lu; Xinhua Wan; Bin Liu; Xianfang Rong; Lei Zhu; Pingping Li; Jiang Li; Ling Wang; Liying Cui; Xiaoliang Wang
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

4.  Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.

Authors:  Ilaria Genovese; Flavia Giamogante; Lucia Barazzuol; Theo Battista; Annarita Fiorillo; Mattia Vicario; Giuseppina D'Alessandro; Raffaela Cipriani; Cristina Limatola; Daniela Rossi; Vincenzo Sorrentino; Elena Poser; Luciana Mosca; Ferdinando Squitieri; Marzia Perluigi; Andrea Arena; Filip van Petegem; Claudia Tito; Francesco Fazi; Carlotta Giorgi; Tito Calì; Andrea Ilari; Gianni Colotti
Journal:  Cell Death Dis       Date:  2020-10-15       Impact factor: 8.469

5.  Sorcin: a novel potential target in therapies of cancers.

Authors:  Xinyi Zhou; Xue Wu; Baoan Chen
Journal:  Cancer Manag Res       Date:  2019-08-05       Impact factor: 3.989

Review 6.  Roles of Sorcin in Drug Resistance in Cancer: One Protein, Many Mechanisms, for a Novel Potential Anticancer Drug Target.

Authors:  Theo Battista; Annarita Fiorillo; Valerio Chiarini; Ilaria Genovese; Andrea Ilari; Gianni Colotti
Journal:  Cancers (Basel)       Date:  2020-04-06       Impact factor: 6.639

7.  Identification of anti-Parkinson's Disease Lead Compounds from Aspergillus ochraceus Targeting Adenosin Receptors A2A.

Authors:  Linzhen Hu; Shuying Tian; Rongrong Wu; Zhou Tong; Wen Jiang; Ping Hu; Xueyang Xiao; Xueke Zhang; Hui Zhou; Qingyi Tong; Yuanyuan Lu; Zhiyong Huang; Yong Chen; Yonghui Zhang
Journal:  ChemistryOpen       Date:  2021-06       Impact factor: 2.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.